Newsletter Archive

  1. 07.25.26 -- Software Product Showcase 7/25/2026
    07/25/26 Pharmaceutical Online Newsletter
  2. 07.24.26 -- How To Avoid The Biggest USP <665> Compliance Trap 7/24/2026
    07/24/26 Pharmaceutical Online Newsletter
  3. 07.23.26 -- STREAM Edition: Analyzing Risk And Ensuring Quality 7/23/2026

    07/23/26

  4. 07.23.26 -- 7 Facilities Pilot PreCheck For Faster Approval 7/23/2026
    07/23/26 Pharmaceutical Online Newsletter
  5. 07.21.26 -- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 3: Building A Compliant Program 7/21/2026
    07/21/26 Pharmaceutical Online Newsletter
  6. 07.17.26 -- Does The FDA's Plausible Mechanism Pathway Revolutionize The Way All Risks Are Analyzed? 7/17/2026
    07/17/26 Pharmaceutical Online Newsletter
  7. 07.16.26 -- Human-Centric Models For Modern Drug Development 7/16/2026

    07/16/26 Pharmaceutical Online Newsletter

  8. 07.16.26 -- What Biopharma Often Overlooks In A Scheduled Shutdown 7/16/2026
    07/16/26 Pharmaceutical Online Newsletter
  9. 07.16.26 -- STREAM Edition: High-Volume GLP-1 Manufacturing: Challenges And Bottlenecks On A Global Scale 7/16/2026

    07/16/26 Pharmaceutical Online Newsletter

  10. 07.14.26 -- Practical Strategies for Contamination Control and EM Compliance 7/14/2026

    07/14/26 Pharmaceutical Online Newsletter